Ian Marshall
Pediatric Endocrinology · New Brunswick, NJNPI 1396760450
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $40,600 of the $51,385 with a category attached, or 79.0%. Neurocrine Biosciences, Inc. accounts for 88.9% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $31,791, more than ten times the $94 reported in 2020. Among pediatric endocrinology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 60 payments — averaging $856.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$46K
- Eton Pharmaceuticals, Inc.$5K
- Sanofi-aventis U.S. LLC$224
- Tolmar, Inc.$176
- Medtronic$146
- AstraZeneca$115
- plus $291 from 5 others
Across 126 payments — averaging $900.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$104K
- Takeda Pharmaceuticals U.S.A., Inc.$7K
- Shire North American Group Inc$2K
What the payments were for
- Consulting fees$40,60079%
- Speaking & faculty fees$4,7309%
- Travel & lodging$3,8768%
- Food & beverage$2,0414%
- Education$1180%
- Other$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 47 | $45,703 |
| Eton Pharmaceuticals, Inc. | 1 | $4,730 |
| Sanofi-aventis U.S. LLC | 2 | $224 |
| Tolmar, Inc. | 1 | $176 |
| Medtronic(2 entities) | 2 | $146 |
| AstraZeneca | 1 | $115 |
| Tandem Diabetes Care, Inc. | 1 | $114 |
| Biomarin Pharmaceutical Inc. | 2 | $108 |
| Johnson & Johnson | 1 | $28 |
| Baxter Healthcare | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CRENESSITY$25,235
- Alkindi$4,730
- TZIELD$224
- FENSOLVI$176
- Strensiq$115
- t:slim X2 Insulin Pump with Control-IQ$114
How this compares
$51,385 in reported general payments places this provider in the 95th percentile of 59 pediatric endocrinology providers in New Jersey.
Other pediatric endocrinology in New Brunswick
- Ahmed KhattabNew Brunswick$70K
- Divya KhuranaNew Brunswick$1K
- Weizhen XuNew Brunswick$1K
- Max SalasNew Brunswick$916
- Mariam GangatNew Brunswick$559
- Elizabeth KornNew Brunswick$402
- Shana MencherNew Brunswick$286
- Min Jung KangNew Brunswick$271
- Swathi SethuramNew Brunswick$142
- Lawrence SilvermanMorristown$492K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.